University of Minnesota. Driven to Discover.
A mother and child in South Kivu province became infected after contact with a patient from Beni.
Lefamulin approval was supported by two phase 3 trials involving moxifloxacin.
With 27 new infections in the past 3 days, the outbreak has grown to 2,888 cases and 1,934 deaths.
Postprescription audit and review showed more promise than preauthorization.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.